Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1995 Jan;72(1):1–3. doi: 10.1136/adc.72.1.1

Respiratory syncytial virus--how soon will we have a vaccine?

G L Toms 1
PMCID: PMC1510974  PMID: 7717728

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alwan W. H., Record F. M., Openshaw P. J. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin Exp Immunol. 1992 Jun;88(3):527–536. doi: 10.1111/j.1365-2249.1992.tb06482.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beem M. Repeated infections with respiratory syncytial virus. J Immunol. 1967 Jun;98(6):1115–1122. [PubMed] [Google Scholar]
  3. Buynak E. B., Weibel R. E., Carlson A. J., McLean A. A., Hilleman M. R. Further investigations of live respiratory syncytial virus vaccine administered parenterally. Proc Soc Exp Biol Med. 1979 Feb;160(2):272–277. doi: 10.3181/00379727-160-40433. [DOI] [PubMed] [Google Scholar]
  4. Cane P. A., Matthews D. A., Pringle C. R. Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide. Virus Res. 1992 Sep 1;25(1-2):15–22. doi: 10.1016/0168-1702(92)90096-r. [DOI] [PubMed] [Google Scholar]
  5. Connors M., Kulkarni A. B., Firestone C. Y., Holmes K. L., Morse H. C., 3rd, Sotnikov A. V., Murphy B. R. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol. 1992 Dec;66(12):7444–7451. doi: 10.1128/jvi.66.12.7444-7451.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Graham B. S., Henderson G. S., Tang Y. W., Lu X., Neuzil K. M., Colley D. G. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol. 1993 Aug 15;151(4):2032–2040. [PubMed] [Google Scholar]
  7. Hendry R. M., Burns J. C., Walsh E. E., Graham B. S., Wright P. F., Hemming V. G., Rodriguez W. J., Kim H. W., Prince G. A., McIntosh K. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis. 1988 Apr;157(4):640–647. doi: 10.1093/infdis/157.4.640. [DOI] [PubMed] [Google Scholar]
  8. Johnson P. R., Jr, Olmsted R. A., Prince G. A., Murphy B. R., Alling D. W., Walsh E. E., Collins P. L. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol. 1987 Oct;61(10):3163–3166. doi: 10.1128/jvi.61.10.3163-3166.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969 Apr;89(4):422–434. doi: 10.1093/oxfordjournals.aje.a120955. [DOI] [PubMed] [Google Scholar]
  10. Kimman T. G., Sol J., Westenbrink F., Straver P. J. A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine. Vet Q. 1989 Oct;11(4):250–253. doi: 10.1080/01652176.1989.9694231. [DOI] [PubMed] [Google Scholar]
  11. Mufson M. A., Belshe R. B., Orvell C., Norrby E. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol. 1987 Aug;25(8):1535–1539. doi: 10.1128/jcm.25.8.1535-1539.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Murphy B. R., Hall S. L., Kulkarni A. B., Crowe J. E., Jr, Collins P. L., Connors M., Karron R. A., Chanock R. M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res. 1994 Apr;32(1):13–36. doi: 10.1016/0168-1702(94)90059-0. [DOI] [PubMed] [Google Scholar]
  13. Murphy B. R., Prince G. A., Walsh E. E., Kim H. W., Parrott R. H., Hemming V. G., Rodriguez W. J., Chanock R. M. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol. 1986 Aug;24(2):197–202. doi: 10.1128/jcm.24.2.197-202.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murphy B. R., Walsh E. E. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol. 1988 Aug;26(8):1595–1597. doi: 10.1128/jcm.26.8.1595-1597.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Prince G. A., Horswood R. L., Koenig D. W., Chanock R. M. Antigenic analysis of a putative new strain of respiratory syncytial virus. J Infect Dis. 1985 Apr;151(4):634–637. doi: 10.1093/infdis/151.4.634. [DOI] [PubMed] [Google Scholar]
  16. Robinson B. S., Everson J. S. Epitope specificities of human serum antibodies reactive with respiratory syncytial virus fusion protein. Arch Virol. 1992;125(1-4):273–286. doi: 10.1007/BF01309644. [DOI] [PubMed] [Google Scholar]
  17. Stott E. J., Taylor G. Respiratory syncytial virus. Brief review. Arch Virol. 1985;84(1-2):1–52. doi: 10.1007/BF01310552. [DOI] [PubMed] [Google Scholar]
  18. Toms G. L. Vaccination against respiratory syncytial virus: problems and progress. FEMS Microbiol Immunol. 1991 Oct;3(5):243–256. doi: 10.1111/j.1574-6968.1991.tb04221.x. [DOI] [PubMed] [Google Scholar]
  19. Tristram D. A., Welliver R. C. Respiratory syncytial virus vaccines: can we improve on nature? Pediatr Ann. 1993 Dec;22(12):715–718. doi: 10.3928/0090-4481-19931201-06. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES